2316

$MRNAB just flushed 21% in about three hours. No FDA letter. No trial failure. Just the two scariest words in biotech: "data coming."

The tape: dead flat $241-245 all morning, then after the US open the floor gave out — $224 to a $194.14 low, live ~$196. The 16:00 UTC candle printed the day's biggest volume bar by a mile. And this wrapper is tiny — CoinGecko has it at rank #2316 with ~$2M in wrapper mcap — so $2.05M of Binance volume today is the entire float changing hands in one session. 1h RSI just printed 10. That is washed out.

The why is on the calendar, not the newswires. On October 24 the ESMO Congress in Madrid gets the full Phase 3 INTerpath-001 data for the Moderna-Merck melanoma vaccine (intismeran autogene + Keytruda) — STAT News is literally on the ground there today, and MarketWatch notes "a lot is riding on this data." The equity is up ~284% since the August positive topline, ~700% this year, highest since 2022. When everyone is long the data, this is what de-risking looks like.

Levels: $254.51 is the ceiling, the $241-245 morning shelf is now overhead resistance, $194.14 the flush low — and below that is air.

Honest risk framing: if the Oct 24 data confirms, a snapback off RSI 10 can be as violent as the flush. If it disappoints, the equity gaps and the token follows. Do not catch falling knives on a binary event — let the data print, then read the tape.

Is this just de-risking before the reveal, or does someone know something? $MRNA